Gandhar Oil Refinery (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 26, 2025, 11:37 am

Competitors of Gandhar Oil Refinery (India) Ltd

All Competitor Stocks of Gandhar Oil Refinery (India) Ltd

Quarterly Result

Last Updated: August 19, 2025, 2:55 pm

Below is a detailed analysis of the quarterly data for Gandhar Oil Refinery (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 903.00 Cr.. The value appears to be declining and may need further review. It has decreased from 962.00 Cr. (Mar 2025) to 903.00 Cr., marking a decrease of 59.00 Cr..
• For Expenses, as of Jun 2025, the value is 857.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 928.00 Cr. (Mar 2025) to 857.00 Cr., marking a decrease of 71.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 12.00 Cr..
• For OPM %, as of Jun 2025, the value is 5.00%. The value appears strong and on an upward trend. It has increased from 3.00% (Mar 2025) to 5.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 14.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 15.00 Cr..
• For Tax %, as of Jun 2025, the value is 18.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 18.00%, marking a decrease of 9.00%.
• For Net Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 14.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.68. The value appears strong and on an upward trend. It has increased from 1.19 (Mar 2025) to 2.68, marking an increase of 1.49.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 1:05 pm

Growth

Last Updated: September 5, 2025, 3:31 pm

Balance Sheet

Last Updated: July 25, 2025, 1:15 pm

Below is a detailed analysis of the balance sheet data for Gandhar Oil Refinery (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,217.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,153.00 Cr. (Mar 2024) to 1,217.00 Cr., marking an increase of 64.00 Cr..
• For Borrowings, as of Mar 2025, the value is 305.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 271.00 Cr. (Mar 2024) to 305.00 Cr., marking an increase of 34.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 418.00 Cr.. The value appears to be improving (decreasing). It has decreased from 497.00 Cr. (Mar 2024) to 418.00 Cr., marking a decrease of 79.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,959.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,940.00 Cr. (Mar 2024) to 1,959.00 Cr., marking an increase of 19.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 450.00 Cr.. The value appears strong and on an upward trend. It has increased from 361.00 Cr. (Mar 2024) to 450.00 Cr., marking an increase of 89.00 Cr..
• For CWIP, as of Mar 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2024) to 8.00 Cr., marking a decrease of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,501.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,570.00 Cr. (Mar 2024) to 1,501.00 Cr., marking a decrease of 69.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,959.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,940.00 Cr. (Mar 2024) to 1,959.00 Cr., marking an increase of 19.00 Cr..

Notably, the Reserves (1,217.00 Cr.) exceed the Borrowings (305.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Gandhar Oil Refinery (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.18. This value is within the healthy range. It has decreased from 16.27 (Mar 24) to 8.18, marking a decrease of 8.09.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.18. This value is within the healthy range. It has decreased from 16.27 (Mar 24) to 8.18, marking a decrease of 8.09.
• For Cash EPS (Rs.), as of Mar 25, the value is 11.19. This value is within the healthy range. It has decreased from 18.95 (Mar 24) to 11.19, marking a decrease of 7.76.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 126.29. It has increased from 125.02 (Mar 24) to 126.29, marking an increase of 1.27.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 126.29. It has increased from 125.02 (Mar 24) to 126.29, marking an increase of 1.27.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 398.13. It has decreased from 420.27 (Mar 24) to 398.13, marking a decrease of 22.14.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 19.27. This value is within the healthy range. It has decreased from 29.49 (Mar 24) to 19.27, marking a decrease of 10.22.
• For PBIT / Share (Rs.), as of Mar 25, the value is 16.63. This value is within the healthy range. It has decreased from 27.43 (Mar 24) to 16.63, marking a decrease of 10.80.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.68. This value is within the healthy range. It has decreased from 21.49 (Mar 24) to 11.68, marking a decrease of 9.81.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.54. This value is within the healthy range. It has decreased from 16.89 (Mar 24) to 8.54, marking a decrease of 8.35.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.18. This value is within the healthy range. It has decreased from 14.36 (Mar 24) to 8.18, marking a decrease of 6.18.
• For PBDIT Margin (%), as of Mar 25, the value is 4.84. This value is below the healthy minimum of 10. It has decreased from 7.01 (Mar 24) to 4.84, marking a decrease of 2.17.
• For PBIT Margin (%), as of Mar 25, the value is 4.17. This value is below the healthy minimum of 10. It has decreased from 6.52 (Mar 24) to 4.17, marking a decrease of 2.35.
• For PBT Margin (%), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 10. It has decreased from 5.11 (Mar 24) to 2.93, marking a decrease of 2.18.
• For Net Profit Margin (%), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 5. It has decreased from 4.01 (Mar 24) to 2.14, marking a decrease of 1.87.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.05. This value is below the healthy minimum of 8. It has decreased from 3.41 (Mar 24) to 2.05, marking a decrease of 1.36.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.47. This value is below the healthy minimum of 15. It has decreased from 11.98 (Mar 24) to 6.47, marking a decrease of 5.51.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.24. This value is within the healthy range. It has decreased from 20.28 (Mar 24) to 11.24, marking a decrease of 9.04.
• For Return On Assets (%), as of Mar 25, the value is 4.08. This value is below the healthy minimum of 5. It has decreased from 7.24 (Mar 24) to 4.08, marking a decrease of 3.16.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.14. This value is within the healthy range. It has decreased from 0.17 (Mar 24) to 0.14, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.00. It has decreased from 2.31 (Mar 24) to 2.00, marking a decrease of 0.31.
• For Current Ratio (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 2.52 (Mar 24) to 2.91, marking an increase of 0.39.
• For Quick Ratio (X), as of Mar 25, the value is 2.01. This value exceeds the healthy maximum of 2. It has increased from 1.79 (Mar 24) to 2.01, marking an increase of 0.22.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.56. This value exceeds the healthy maximum of 8. It has increased from 7.86 (Mar 24) to 8.56, marking an increase of 0.70.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.11. This value is below the healthy minimum of 20. It has increased from 2.84 (Mar 24) to 6.11, marking an increase of 3.27.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.61. This value is below the healthy minimum of 20. It has increased from 2.48 (Mar 24) to 4.61, marking an increase of 2.13.
• For Earning Retention Ratio (%), as of Mar 25, the value is 93.89. This value exceeds the healthy maximum of 70. It has decreased from 97.16 (Mar 24) to 93.89, marking a decrease of 3.27.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.39. This value exceeds the healthy maximum of 70. It has decreased from 97.52 (Mar 24) to 95.39, marking a decrease of 2.13.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.90. This value is within the healthy range. It has decreased from 4.96 (Mar 24) to 3.90, marking a decrease of 1.06.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 3. It has decreased from 3.84 (Mar 24) to 2.73, marking a decrease of 1.11.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,466.03. It has decreased from 1,937.66 (Mar 24) to 1,466.03, marking a decrease of 471.63.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.37, marking a decrease of 0.10.
• For EV / EBITDA (X), as of Mar 25, the value is 7.77. This value is within the healthy range. It has increased from 6.71 (Mar 24) to 7.77, marking an increase of 1.06.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.35, marking a decrease of 0.12.
• For Retention Ratios (%), as of Mar 25, the value is 93.88. This value exceeds the healthy maximum of 70. It has decreased from 97.15 (Mar 24) to 93.88, marking a decrease of 3.27.
• For Price / BV (X), as of Mar 25, the value is 1.12. This value is within the healthy range. It has decreased from 1.67 (Mar 24) to 1.12, marking a decrease of 0.55.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.35, marking a decrease of 0.12.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.05, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness